Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models

Bibliographic Details
Main Authors: Parisi, Fabio, González, Ana M, Nadler, Yasmine, Camp, Robert L, Rimm, David L, Kluger, Harriet M, Kluger, Yuval
Format: Online
Language:English
Published: BioMed Central 2010
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096952/
id pubmed-3096952
recordtype oai_dc
spelling pubmed-30969522011-05-18 Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models Parisi, Fabio González, Ana M Nadler, Yasmine Camp, Robert L Rimm, David L Kluger, Harriet M Kluger, Yuval Research Article BioMed Central 2010 2010-09-01 /pmc/articles/PMC3096952/ /pubmed/20809974 http://dx.doi.org/10.1186/bcr2633 Text en Copyright ©2010 Parisi et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Parisi, Fabio
González, Ana M
Nadler, Yasmine
Camp, Robert L
Rimm, David L
Kluger, Harriet M
Kluger, Yuval
spellingShingle Parisi, Fabio
González, Ana M
Nadler, Yasmine
Camp, Robert L
Rimm, David L
Kluger, Harriet M
Kluger, Yuval
Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models
author_facet Parisi, Fabio
González, Ana M
Nadler, Yasmine
Camp, Robert L
Rimm, David L
Kluger, Harriet M
Kluger, Yuval
author_sort Parisi, Fabio
title Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models
title_short Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models
title_full Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models
title_fullStr Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models
title_full_unstemmed Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models
title_sort benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models
description
publisher BioMed Central
publishDate 2010
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096952/
_version_ 1611454295275732992